Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.

Diabetes care - 1 May 1999

Wägner A M, Pérez A, Calvo F, Bonet R, Castellví A, Ordóñez J

Abstract excerpt

OBJECTIVE: Apolipoprotein(B) [apo(B)] reflects the total mass of atherogenic particles (VLDL, IDL, and LDL), and its increase is associated with cardiovascular disease independently of LDL cholesterol (LDLc) levels. Apo(B) determination has been recently standardized, but attention to regional reference limits is advisable. Our aim was to analyze the frequency of dyslipidemic phenotypes, including those dependent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins B
Share to Cholesterol

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Cholesterol, VLDL

Share to Diabetic Angiopathies

Share to Hyperlipidemias

Share to Reference Values

Source

Identifiers

PMID: 10332687
DOI: 10.2337/diacare.22.5.812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.PMID 10332687Read ↗

An adverse lipoprotein phenotype-hypertriglyceridaemic hyperapolipoprotein B-and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort study.Semantic proximity Read ↗

What is the best predictor of the atherogenic LDL subclass phenotype 'pattern B' in patients with type 2 diabetes mellitus?Semantic proximity Read ↗

LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Lipids, lipoproteins and apolipoprotein (a) isoforms in type 2 diabetic patients.Semantic proximity Read ↗

Diabetes Mellitus and Lipoprotein(a): A Determinant Interaction in Micro- and Macrovascular DamageSemantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Atherogenic lipid phenotype in a general group of subjects.Semantic proximity Read ↗

Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.Semantic proximity Read ↗

Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes.Semantic proximity Read ↗

Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.